Endo International Ordinary Shares reported $1.18B in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Aerie Pharmaceuticals AERI:US USD 62.8M 11.35M
Amarin AMRN:US USD 95.02M 62.25M
Ani Pharmaceuticals ANIP:US USD 88.82M 2.05M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Eli Lilly And LLY:US USD 5.27B 12.8M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Hikma Pharmaceutical HIK:LN USD 964M 118M
Horizon Pharma HZNP:US USD 764.75M 23.1M
Lannett LCI:US USD 88.11M 64.04M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Patterson Companies PDCO:US USD 1.57B 77.69M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 13.23B 2.41B
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Takeda 4502:JP JPY 897.87B 75.92B
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.5M 4.28M
Zoetis ZTS:US USD 1.34B 47M